Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucokinase (hexokinase 4) | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hexokinase family protein | glucokinase (hexokinase 4) | 465 aa | 470 aa | 30.0 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | hexokinase | 0.0096 | 0.7111 | 1 |
Echinococcus multilocularis | hexokinase | 0.0096 | 0.7111 | 1 |
Onchocerca volvulus | 0.0107 | 0.8528 | 0.8528 | |
Onchocerca volvulus | 0.0096 | 0.7111 | 0.7111 | |
Brugia malayi | Low-density lipoprotein receptor repeat class B containing protein | 0.005 | 0.1249 | 0.1249 |
Leishmania major | hexokinase, putative | 0.0096 | 0.7111 | 1 |
Loa Loa (eye worm) | hexokinase | 0.006 | 0.2565 | 0.2565 |
Toxoplasma gondii | hexokinase | 0.0096 | 0.7111 | 1 |
Echinococcus multilocularis | hexokinase type 2 | 0.0096 | 0.7111 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.2376 | 0.2376 |
Brugia malayi | Hexokinase family protein | 0.006 | 0.2565 | 0.2565 |
Onchocerca volvulus | 0.0096 | 0.7111 | 0.7111 | |
Loa Loa (eye worm) | hexokinase type II | 0.0096 | 0.7111 | 0.7111 |
Trypanosoma brucei | hexokinase | 0.0096 | 0.7111 | 0.5 |
Echinococcus granulosus | hexokinase | 0.0096 | 0.7111 | 1 |
Onchocerca volvulus | 0.006 | 0.2565 | 0.2565 | |
Onchocerca volvulus | 0.0107 | 0.8528 | 0.8528 | |
Leishmania major | hexokinase, putative | 0.0096 | 0.7111 | 1 |
Schistosoma mansoni | hexokinase | 0.0096 | 0.7111 | 0.8339 |
Echinococcus granulosus | hexokinase type 2 | 0.0096 | 0.7111 | 1 |
Trypanosoma cruzi | hexokinase, putative | 0.0096 | 0.7111 | 1 |
Trypanosoma cruzi | hexokinase, putative | 0.0096 | 0.7111 | 1 |
Treponema pallidum | hexokinase (hxk) | 0.0096 | 0.7111 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0107 | 0.8528 | 1 |
Loa Loa (eye worm) | hexokinase | 0.0096 | 0.7111 | 0.7111 |
Onchocerca volvulus | 0.0119 | 1 | 1 | |
Trypanosoma brucei | hexokinase | 0.0096 | 0.7111 | 0.5 |
Loa Loa (eye worm) | low-density lipoprotein receptor repeat class B containing protein | 0.005 | 0.1249 | 0.1249 |
Onchocerca volvulus | 0.0107 | 0.8528 | 0.8528 | |
Echinococcus multilocularis | hexokinase | 0.0096 | 0.7111 | 1 |
Echinococcus granulosus | hexokinase | 0.0096 | 0.7111 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.8528 | 0.8528 |
Entamoeba histolytica | hexokinase 1 | 0.0096 | 0.7111 | 0.5 |
Onchocerca volvulus | 0.0107 | 0.8528 | 0.8528 | |
Loa Loa (eye worm) | hypothetical protein | 0.0119 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.1249 | 0.1249 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0052 | 0.1535 | 0.18 |
Echinococcus granulosus | hexokinase | 0.0096 | 0.7111 | 1 |
Entamoeba histolytica | hexokinase 2 | 0.0096 | 0.7111 | 0.5 |
Onchocerca volvulus | Arrow homolog | 0.005 | 0.1249 | 0.1249 |
Onchocerca volvulus | Hexokinase homolog | 0.006 | 0.2565 | 0.2565 |
Brugia malayi | Hexokinase family protein | 0.0096 | 0.7111 | 0.7111 |
Brugia malayi | SEA domain containing protein | 0.0107 | 0.8528 | 0.8528 |
Brugia malayi | hexokinase | 0.0096 | 0.7111 | 0.7111 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.3232 | 0.3232 |
Plasmodium falciparum | hexokinase | 0.0096 | 0.7111 | 1 |
Loa Loa (eye worm) | DOMON domain-containing protein | 0.0107 | 0.8528 | 0.8528 |
Plasmodium vivax | hexokinase, putative | 0.0096 | 0.7111 | 1 |
Onchocerca volvulus | 0.0096 | 0.7111 | 0.7111 | |
Loa Loa (eye worm) | hexokinase | 0.0096 | 0.7111 | 0.7111 |
Trypanosoma brucei | hexokinase, putative | 0.0096 | 0.7111 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = -3.1 % | Antidiabetic activity in glucose-treated C57BL/J6 db/db mouse assessed as reduction of glucose AUC at 50 mg/kg, po preincubated for 30 mins followed by glucose challenge measured after 30 to 180 mins by oral glucose tolerance test relative to control | ChEMBL. | 24588963 |
EC50 (binding) | = 0.103 uM | Activation of recombinant human pancreatic glucokinase using 10 mM glucose by spectrophotometry | ChEMBL. | 24588963 |
S50 (binding) | = 1.78 mM | Activity of recombinant human pancreatic glucokinase assessed as glucose half-maximal saturation concentration | ChEMBL. | 24588963 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.